Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N0JC
|
||||
Former ID |
DNC011933
|
||||
Drug Name |
RTI-5989-23
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [534631] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H26ClNO
|
||||
Canonical SMILES |
CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC=CC3=CC=CC=C3Cl
|
||||
InChI |
1S/C22H26ClNO/c1-17-16-24(13-6-8-18-7-3-4-11-21(18)23)14-12-22(17,2)19-9-5-10-20(25)15-19/h3-11,15,17,25H,12-14,16H2,1-2H3/b8-6+/t17-,22+/m0/s1
|
||||
InChIKey |
RRGWRLNJBLFYOG-KISUKSLOSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [534631] | |
Kappa-type opioid receptor | Target Info | Inhibitor | [534631] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Opioid prodynorphin pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.